Results 51 to 60 of about 50,365 (225)

Respuesta terapéutica a Citarabina y Doxorrubicina en pacientes diagnosticado con Leucemia Mieloide Aguda (LMA) en el Hospital Escuela Dr. Roberto Calderón Gutiérrez durante el período Enero 2008-Diciembre 2012 [PDF]

open access: yes, 2016
Leucemia mieloide aguda (LMA) es un grupo heterogéneo de leucemias procedentes de la línea mieloide, representa el 8% de las leucemia del adulto. Su sintomatología es variada siendo los síntomas constitucionales los de mayor frecuencia y síndrome anémico
Acevedo Mora, María Victoria   +1 more
core  

Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

open access: yesInternational Journal of Cancer, Volume 157, Issue 3, Page 480-489, 1 August 2025.
What's new? In this prospective study, the authors evaluated the discrimination capacity of 92 cancer‐related proteins as potential early detection biomarkers for endometrial cancer using blood samples from two large‐scale European population cohorts (EPIC and Janus).
Victoria Cooley   +12 more
wiley   +1 more source

Frecuencia de Hemocomponentes Transfundidos Según Sistema ABO y RHESUS en niños con Anemia o Leucemia que asistieron, al Área de Hemato-oncología del Hospital Manuel de Jesus Rivera " La Mascota", Mayo- Noviembre 2014 [PDF]

open access: yes, 2016
El presente estudio se realizó con el propósito de determinar la frecuencia de Hemocomponentes transfundidos según sistemas ABO y Rhesus en niños con anemia o leucemia que asistieron al área de hemato-oncología del hospital Manuel de Jesús Rivera ¨LA ...
Sandino Velásquez, Jonathan Rogelio   +2 more
core  

Correlação da doença periodontal com a leucemia: revisão bibliográfica [PDF]

open access: yes, 2015
Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas MonizA Leucemia é uma doença oncológica grave provocada pela desordem dos precursores hematopoiéticos ao nível da medula óssea, resultando na diferenciação e ...
Vieira, Joana Carolina de Nóbrega
core  

Acute Myeloid Leukemia t(8;21) after treatment for hyperthyroidism using radioactive iodine: Secondary Leukemia? [PDF]

open access: yes, 2002
Acute leukemia following treatment with Iodine131 is a rare event. The possible carcinogenic effect of Iodine131 is still not clear and a large series of cases did not show an increased incidence of cancer.
Bahia, Daniella Marcia Maranhão   +4 more
core   +3 more sources

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry

open access: yes
HemaSphere, Volume 10, Issue 2, February 2026.
Noemí Puig   +24 more
wiley   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

open access: yesMolecular Oncology, Volume 19, Issue 6, Page 1687-1706, June 2025.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy   +12 more
wiley   +1 more source

DIAGNÓSTICOS E INTERVENÇÕES DE ENFERMAGEM PARA PACIENTE COM LEUCEMIA LINFOCÍTICA AGUDA: ESTUDO DE CASO CLÍNICO

open access: yesRevista de Ciências da Saúde Nova Esperança, 2004
As Leucemias Linfocíticas Agudas (LLA) encontram-se na classificação dos cânceres hematopoiéticos e caracterizam-se pela produção excessiva de linfócitos malignos.
Nailze Figueiredo Souza de Oliveira   +3 more
doaj   +1 more source

Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work‐Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping

open access: yesAmerican Journal of Hematology, Volume 100, Issue 6, Page 1029-1048, June 2025.
ABSTRACT The latest updates to the classification of hematolymphoid malignancies using the World Health Organization (WHO, 5th ed.) and ICC (International Consensus Classification) criteria highlight the critical need for comprehensive and precise cytogenomic data for diagnosis, prognostication, and treatment.
Rashmi Kanagal‐Shamanna   +18 more
wiley   +1 more source

Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2004
Gemtuzumab Ozogamicina (GO) é um derivado semi-sintético de caliqueamicina, um antibiótico citotóxico ligado a um anticorpo monoclonal direcionado contra antígeno CD33 presente nos mieloblastos leucêmicos.
Celso M. Massumoto   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy